<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Tue, 11 Aug 2026 06:58:54 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>agilon health Inc (AGL) PT Raised to $146 at Wells Fargo</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/agilon+health+Inc+%28AGL%29+PT+Raised+to+%24146+at+Wells+Fargo/26900987.html</link>
   <description>Wells Fargo analyst Stephen Baxter raised the price target on agilon health Inc (NYSE: AGL) to $146.00  (from $141.00) while maintaining a Overweight rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/agilon+health+Inc+%28AGL%29+PT+Raised+to+%24146+at+Wells+Fargo/26900987.html</guid>
   <pubDate>Tue, 11 Aug 2026 06:58:54 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGL</category>
   	  </item>
  <item>
   <title>Citi Upgrades agilon health Inc (AGL) to Neutral</title>
   <link>http://www.streetinsider.com/Upgrades/Citi+Upgrades+agilon+health+Inc+%28AGL%29+to+Neutral/26897878.html</link>
   <description>&lt;p&gt;Citi analyst Daniel Grosslight upgraded agilon health Inc (NYSE: AGL) from Sell to Neutral with a price target of $115.00 (from $105.00).&lt;/p&gt;&lt;p&gt;For an analyst ratings summary and ratings history on agilon health Inc &lt;a href=&quot;http://www.streetinsider.com/rating_history.php?q=AGL&quot;&gt;click here&lt;/a&gt;. For more ratings news on agilon health Inc &lt;a href=&quot;http://www.streetinsider.com/stock_lookup_news.php?q=AGL&amp;amp;type=analyst&quot;&gt;click here&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;Shares of agilon health Inc closed at $95.51 yesterday.&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Upgrades/Citi+Upgrades+agilon+health+Inc+%28AGL%29+to+Neutral/26897878.html</guid>
   <pubDate>Mon, 10 Aug 2026 16:08:49 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGL</category>
   	  </item>
  <item>
   <title>agilon health Inc (AGL) PT Raised to $116 at Baird</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/agilon+health+Inc+%28AGL%29+PT+Raised+to+%24116+at+Baird/26879618.html</link>
   <description>Baird analyst Michael Ha raised the price target on agilon health Inc (NYSE: AGL) to $116.00  (from $35.00) while maintaining a Neutral rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/agilon+health+Inc+%28AGL%29+PT+Raised+to+%24116+at+Baird/26879618.html</guid>
   <pubDate>Thu, 06 Aug 2026 08:28:43 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGL</category>
   	  </item>
  <item>
   <title>agilon health Inc (AGL) PT Raised to $140 at Benchmark</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/agilon+health+Inc+%28AGL%29+PT+Raised+to+%24140+at+Benchmark/26879560.html</link>
   <description>Benchmark analyst Bill Sutherland raised the price target on agilon health Inc (NYSE: AGL) to $140.00  (from $95.00) while maintaining a Buy rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/agilon+health+Inc+%28AGL%29+PT+Raised+to+%24140+at+Benchmark/26879560.html</guid>
   <pubDate>Thu, 06 Aug 2026 08:19:21 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGL</category>
   	  </item>
  <item>
   <title>agilon health Inc (AGL) PT Raised to $112 at Truist Securities</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/agilon+health+Inc+%28AGL%29+PT+Raised+to+%24112+at+Truist+Securities/26878730.html</link>
   <description>Truist Securities analyst Jailendra Singh raised the price target on agilon health Inc (NYSE: AGL) to $112.00  (from $67.00) while maintaining a Hold rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/agilon+health+Inc+%28AGL%29+PT+Raised+to+%24112+at+Truist+Securities/26878730.html</guid>
   <pubDate>Thu, 06 Aug 2026 07:23:19 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGL</category>
   	  </item>
  <item>
   <title>agilon health Inc (AGL) PT Raised to $111 at Barclays</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/agilon+health+Inc+%28AGL%29+PT+Raised+to+%24111+at+Barclays/26876951.html</link>
   <description>Barclays analyst Andrew Mok raised the price target on agilon health Inc (NYSE: AGL) to $111.00  (from $81.00) while maintaining a Equalweight rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/agilon+health+Inc+%28AGL%29+PT+Raised+to+%24111+at+Barclays/26876951.html</guid>
   <pubDate>Thu, 06 Aug 2026 04:18:05 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGL</category>
   	  </item>
  <item>
   <title>Agilon Health Inc. (AGL) Tops Q2 EPS by 96c ; Offers Guidance</title>
   <link>http://www.streetinsider.com/Earnings/Agilon+Health+Inc.+%28AGL%29+Tops+Q2+EPS+by+96c+%3B+Offers+Guidance/26874019.html</link>
   <description>&lt;p&gt;Agilon Health Inc. (NYSE: AGL) reported Q2 EPS of $1.04, $0.96 better than the analyst estimate of $0.08. Revenue for the quarter came in at $1.49 billion versus the consensus estimate of $1.44 billion.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;GUIDANCE:&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;Agilon Health Inc. sees Q3 2026 revenue of $1.44-1.47 billion, versus the consensus of $1.41 billion.&lt;/p&gt;&lt;p&gt;For earnings history and earnings-related data on Agilon Health Inc. (AGL) &lt;a href=&quot;http://www.streetinsider.com/ec_earnings.php?q=AGL&quot;&gt;click here&lt;/a&gt;.&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Earnings/Agilon+Health+Inc.+%28AGL%29+Tops+Q2+EPS+by+96c+%3B+Offers+Guidance/26874019.html</guid>
   <pubDate>Wed, 05 Aug 2026 16:07:48 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGL</category>
   	  </item>
  <item>
   <title>Agilon Health Inc. (AGL) Tops Q2 EPS by 96c ; Offers Guidance</title>
   <link>http://www.streetinsider.com/Guidance/Agilon+Health+Inc.+%28AGL%29+Tops+Q2+EPS+by+96c+%3B+Offers+Guidance/26874019.html</link>
   <description>&lt;p&gt;Agilon Health Inc. (NYSE: AGL) reported Q2 EPS of $1.04, $0.96 better than the analyst estimate of $0.08. Revenue for the quarter came in at $1.49 billion versus the consensus estimate of $1.44 billion.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;GUIDANCE:&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;Agilon Health Inc. sees Q3 2026 revenue of $1.44-1.47 billion, versus the consensus of $1.41 billion.&lt;/p&gt;&lt;p&gt;For earnings history and earnings-related data on Agilon Health Inc. (AGL) &lt;a href=&quot;http://www.streetinsider.com/ec_earnings.php?q=AGL&quot;&gt;click here&lt;/a&gt;.&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Guidance/Agilon+Health+Inc.+%28AGL%29+Tops+Q2+EPS+by+96c+%3B+Offers+Guidance/26874019.html</guid>
   <pubDate>Wed, 05 Aug 2026 16:07:48 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGL</category>
   	  </item>
  <item>
   <title>agilon health Reports Second Quarter 2026 Results</title>
   <link>http://www.streetinsider.com/Press+Releases/agilon+health+Reports+Second+Quarter+2026+Results/26873871.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;b&gt;&lt;i&gt;Revenue increase 7% to $1.49 billion&lt;/i&gt;&lt;/b&gt;

&lt;/p&gt;&lt;p class=&quot;bwalignc&quot;&gt;
&lt;b&gt;&lt;i&gt;Raises Full-Year 2026 Total Revenues, Medical Margin, and Adjusted EBITDA Guidance&lt;/i&gt;&lt;/b&gt;

&lt;/p&gt;
&lt;p&gt;    WESTERVILLE, Ohio--(BUSINESS WIRE)--
agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced results for the second quarter ended June 30, 2026. In addition, the company increased full-year 2026 guidance for total revenues, medical margin, and Adjusted EBITDA.

&lt;/p&gt;&lt;p&gt;
“Our second quarter results exceeded our expectations, demonstrating meaningful progress across agilon's strategic initiatives and reinforcing our confidence in the strength of our Total Care Model,” said Tim O’Rourke, Chief Executive Officer of agilon</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/agilon+health+Reports+Second+Quarter+2026+Results/26873871.html</guid>
   <pubDate>Wed, 05 Aug 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50348148</category>
   	  </item>
  <item>
   <title>agilon health Reports Second Quarter 2026 Results</title>
   <link>http://www.streetinsider.com/Press+Releases/agilon+health+Reports+Second+Quarter+2026+Results/26873871.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;b&gt;&lt;i&gt;Revenue increase 7% to $1.49 billion&lt;/i&gt;&lt;/b&gt;

&lt;/p&gt;&lt;p class=&quot;bwalignc&quot;&gt;
&lt;b&gt;&lt;i&gt;Raises Full-Year 2026 Total Revenues, Medical Margin, and Adjusted EBITDA Guidance&lt;/i&gt;&lt;/b&gt;

&lt;/p&gt;
&lt;p&gt;    WESTERVILLE, Ohio--(BUSINESS WIRE)--
agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced results for the second quarter ended June 30, 2026. In addition, the company increased full-year 2026 guidance for total revenues, medical margin, and Adjusted EBITDA.

&lt;/p&gt;&lt;p&gt;
“Our second quarter results exceeded our expectations, demonstrating meaningful progress across agilon's strategic initiatives and reinforcing our confidence in the strength of our Total Care Model,” said Tim O’Rourke, Chief Executive Officer of agilon</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/agilon+health+Reports+Second+Quarter+2026+Results/26873871.html</guid>
   <pubDate>Wed, 05 Aug 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50348148</category>
   	  </item>
  <item>
   <title>agilon health Reports Second Quarter 2026 Results</title>
   <link>http://www.streetinsider.com/Business+Wire/agilon+health+Reports+Second+Quarter+2026+Results/26873871.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;b&gt;&lt;i&gt;Revenue increase 7% to $1.49 billion&lt;/i&gt;&lt;/b&gt;

&lt;/p&gt;&lt;p class=&quot;bwalignc&quot;&gt;
&lt;b&gt;&lt;i&gt;Raises Full-Year 2026 Total Revenues, Medical Margin, and Adjusted EBITDA Guidance&lt;/i&gt;&lt;/b&gt;

&lt;/p&gt;
&lt;p&gt;    WESTERVILLE, Ohio--(BUSINESS WIRE)--
agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced results for the second quarter ended June 30, 2026. In addition, the company increased full-year 2026 guidance for total revenues, medical margin, and Adjusted EBITDA.

&lt;/p&gt;&lt;p&gt;
“Our second quarter results exceeded our expectations, demonstrating meaningful progress across agilon's strategic initiatives and reinforcing our confidence in the strength of our Total Care Model,” said Tim O’Rourke, Chief Executive Officer of agilon</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/agilon+health+Reports+Second+Quarter+2026+Results/26873871.html</guid>
   <pubDate>Wed, 05 Aug 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50348148</category>
   	  </item>
  <item>
   <title>agilon health Reports Second Quarter 2026 Results</title>
   <link>http://www.streetinsider.com/Business+Wire/agilon+health+Reports+Second+Quarter+2026+Results/26873871.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;b&gt;&lt;i&gt;Revenue increase 7% to $1.49 billion&lt;/i&gt;&lt;/b&gt;

&lt;/p&gt;&lt;p class=&quot;bwalignc&quot;&gt;
&lt;b&gt;&lt;i&gt;Raises Full-Year 2026 Total Revenues, Medical Margin, and Adjusted EBITDA Guidance&lt;/i&gt;&lt;/b&gt;

&lt;/p&gt;
&lt;p&gt;    WESTERVILLE, Ohio--(BUSINESS WIRE)--
agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced results for the second quarter ended June 30, 2026. In addition, the company increased full-year 2026 guidance for total revenues, medical margin, and Adjusted EBITDA.

&lt;/p&gt;&lt;p&gt;
“Our second quarter results exceeded our expectations, demonstrating meaningful progress across agilon's strategic initiatives and reinforcing our confidence in the strength of our Total Care Model,” said Tim O’Rourke, Chief Executive Officer of agilon</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/agilon+health+Reports+Second+Quarter+2026+Results/26873871.html</guid>
   <pubDate>Wed, 05 Aug 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50348148</category>
   	  </item>
  <item>
   <title>Form  4          agilon health, inc.       For: Aug 01  Filed by: Zamore Denise</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++agilon+health%2C+inc.+++++++For%3A+Aug+01++Filed+by%3A+Zamore+Denise/26866836.html</link>
   <description>si-local-file:///var/storage/secattach/20260804/26866836.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++agilon+health%2C+inc.+++++++For%3A+Aug+01++Filed+by%3A+Zamore+Denise/26866836.html</guid>
   <pubDate>Tue, 04 Aug 2026 16:23:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50348148</category>
   	  </item>
  <item>
   <title>Form  4          agilon health, inc.       For: Aug 01  Filed by: Zamore Denise</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++agilon+health%2C+inc.+++++++For%3A+Aug+01++Filed+by%3A+Zamore+Denise/26866836.html</link>
   <description>si-local-file:///var/storage/secattach/20260804/26866836.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++agilon+health%2C+inc.+++++++For%3A+Aug+01++Filed+by%3A+Zamore+Denise/26866836.html</guid>
   <pubDate>Tue, 04 Aug 2026 16:23:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50348148</category>
   	  </item>
  <item>
   <title>Citi Downgrades agilon health Inc (AGL) to Sell</title>
   <link>http://www.streetinsider.com/Downgrades/Citi+Downgrades+agilon+health+Inc+%28AGL%29+to+Sell/26803983.html</link>
   <description>&lt;p&gt;Citi analyst Daniel Grosslight downgraded agilon health Inc (NYSE: AGL) from Neutral to Sell.&lt;/p&gt;
&lt;p&gt;For an analyst ratings summary and ratings history on agilon health Inc &lt;a href=&quot;http://www.streetinsider.com/rating_history.php?q=AGL&quot;&gt;click here&lt;/a&gt;. For more ratings news on agilon health Inc &lt;a href=&quot;http://www.streetinsider.com/stock_lookup_news.php?q=AGL&amp;amp;type=analyst&quot;&gt;click here&lt;/a&gt;.&lt;/p&gt;
&lt;p&gt;Shares of agilon health Inc closed at $119.88 yesterday.&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Downgrades/Citi+Downgrades+agilon+health+Inc+%28AGL%29+to+Sell/26803983.html</guid>
   <pubDate>Thu, 23 Jul 2026 06:17:37 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGL</category>
   	  </item>
  <item>
   <title>agilon health Inc (AGL) PT Raised to $141 at Wells Fargo</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/agilon+health+Inc+%28AGL%29+PT+Raised+to+%24141+at+Wells+Fargo/26759319.html</link>
   <description>Wells Fargo analyst Stephen Baxter raised the price target on agilon health Inc (NYSE: AGL) to $141.00  (from $72.00) while maintaining a Overweight rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/agilon+health+Inc+%28AGL%29+PT+Raised+to+%24141+at+Wells+Fargo/26759319.html</guid>
   <pubDate>Mon, 13 Jul 2026 06:28:22 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGL</category>
   	  </item>
  <item>
   <title>agilon health Inc (AGL) PT Raised to $141 at Wells Fargo</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/agilon+health+Inc+%28AGL%29+PT+Raised+to+%24141+at+Wells+Fargo/26759315.html</link>
   <description>Wells Fargo analyst Stephen Baxter raised the price target on agilon health Inc (NYSE: AGL) to $141.00  (from $72.00) while maintaining a Overweight rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/agilon+health+Inc+%28AGL%29+PT+Raised+to+%24141+at+Wells+Fargo/26759315.html</guid>
   <pubDate>Mon, 13 Jul 2026 06:28:15 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGL</category>
   	  </item>
  <item>
   <title>agilon health ACOs report $229M in gross savings for 2024</title>
   <link>http://www.streetinsider.com/Corporate+News/agilon+health+ACOs+report+%24229M+in+gross+savings+for+2024/26755453.html</link>
   <description>&lt;p&gt;Agilon Health (NYSE: AGL) reported that its Accountable Care Organizations achieved $229 million in gross savings during the 2024 performance year of the ACO Realizing Equity, Access and Community Health (ACO REACH) model, representing a 13.6% gross savings rate. Of that total, $54 million went to the Medicare Trust Fund.&lt;/p&gt;&lt;p&gt;The company's eight REACH ACOs operate under full risk and were responsible for the total cost and quality of care for approximately 121,000 Traditional Medicare beneficiaries in 2024. The ACOs included 1,500 primary care physicians operating across 13 communities in Hawaii, New York, North Carolina, Ohio, Pennsylvania and Texas.&lt;/p&gt;&lt;p&gt;The average quality</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/agilon+health+ACOs+report+%24229M+in+gross+savings+for+2024/26755453.html</guid>
   <pubDate>Fri, 10 Jul 2026 08:30:44 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGL</category>
   	  </item>
  <item>
   <title>agilon health Reports ACO REACH Model Results for 2024 Performance Year</title>
   <link>http://www.streetinsider.com/Press+Releases/agilon+health+Reports+ACO+REACH+Model+Results+for+2024+Performance+Year/26755441.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;b&gt;&lt;i&gt;In 2024, agilon REACH ACOs achieved $229 million in gross savings and 96% quality score&lt;/i&gt;&lt;/b&gt;

&lt;/p&gt;&lt;p class=&quot;bwalignc&quot;&gt;
&lt;b&gt;&lt;i&gt;Since joining the model in 2021, agilon REACH ACOs achieved $510 million in gross savings, including &lt;/i&gt;&lt;i&gt;$125 million in savings to Medicare Trust Fund&lt;/i&gt;&lt;/b&gt;

&lt;/p&gt;
&lt;p&gt;    WESTERVILLE, Ohio--(BUSINESS WIRE)--
agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that its Accountable Care Organizations (ACOs) achieved $229 million in gross savings (13.6% gross savings rate), including $54 million savings in the Medicare Trust Fund, during the 2024 performance year of the ACO Realizing Equity, Access and</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/agilon+health+Reports+ACO+REACH+Model+Results+for+2024+Performance+Year/26755441.html</guid>
   <pubDate>Fri, 10 Jul 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50348148</category>
   	  </item>
  <item>
   <title>agilon health Reports ACO REACH Model Results for 2024 Performance Year</title>
   <link>http://www.streetinsider.com/Press+Releases/agilon+health+Reports+ACO+REACH+Model+Results+for+2024+Performance+Year/26755441.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;b&gt;&lt;i&gt;In 2024, agilon REACH ACOs achieved $229 million in gross savings and 96% quality score&lt;/i&gt;&lt;/b&gt;

&lt;/p&gt;&lt;p class=&quot;bwalignc&quot;&gt;
&lt;b&gt;&lt;i&gt;Since joining the model in 2021, agilon REACH ACOs achieved $510 million in gross savings, including &lt;/i&gt;&lt;i&gt;$125 million in savings to Medicare Trust Fund&lt;/i&gt;&lt;/b&gt;

&lt;/p&gt;
&lt;p&gt;    WESTERVILLE, Ohio--(BUSINESS WIRE)--
agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that its Accountable Care Organizations (ACOs) achieved $229 million in gross savings (13.6% gross savings rate), including $54 million savings in the Medicare Trust Fund, during the 2024 performance year of the ACO Realizing Equity, Access and</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/agilon+health+Reports+ACO+REACH+Model+Results+for+2024+Performance+Year/26755441.html</guid>
   <pubDate>Fri, 10 Jul 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50348148</category>
   	  </item>
  <item>
   <title>agilon health Reports ACO REACH Model Results for 2024 Performance Year</title>
   <link>http://www.streetinsider.com/Business+Wire/agilon+health+Reports+ACO+REACH+Model+Results+for+2024+Performance+Year/26755441.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;b&gt;&lt;i&gt;In 2024, agilon REACH ACOs achieved $229 million in gross savings and 96% quality score&lt;/i&gt;&lt;/b&gt;

&lt;/p&gt;&lt;p class=&quot;bwalignc&quot;&gt;
&lt;b&gt;&lt;i&gt;Since joining the model in 2021, agilon REACH ACOs achieved $510 million in gross savings, including &lt;/i&gt;&lt;i&gt;$125 million in savings to Medicare Trust Fund&lt;/i&gt;&lt;/b&gt;

&lt;/p&gt;
&lt;p&gt;    WESTERVILLE, Ohio--(BUSINESS WIRE)--
agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that its Accountable Care Organizations (ACOs) achieved $229 million in gross savings (13.6% gross savings rate), including $54 million savings in the Medicare Trust Fund, during the 2024 performance year of the ACO Realizing Equity, Access and</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/agilon+health+Reports+ACO+REACH+Model+Results+for+2024+Performance+Year/26755441.html</guid>
   <pubDate>Fri, 10 Jul 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50348148</category>
   	  </item>
  <item>
   <title>agilon health Reports ACO REACH Model Results for 2024 Performance Year</title>
   <link>http://www.streetinsider.com/Business+Wire/agilon+health+Reports+ACO+REACH+Model+Results+for+2024+Performance+Year/26755441.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;b&gt;&lt;i&gt;In 2024, agilon REACH ACOs achieved $229 million in gross savings and 96% quality score&lt;/i&gt;&lt;/b&gt;

&lt;/p&gt;&lt;p class=&quot;bwalignc&quot;&gt;
&lt;b&gt;&lt;i&gt;Since joining the model in 2021, agilon REACH ACOs achieved $510 million in gross savings, including &lt;/i&gt;&lt;i&gt;$125 million in savings to Medicare Trust Fund&lt;/i&gt;&lt;/b&gt;

&lt;/p&gt;
&lt;p&gt;    WESTERVILLE, Ohio--(BUSINESS WIRE)--
agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that its Accountable Care Organizations (ACOs) achieved $229 million in gross savings (13.6% gross savings rate), including $54 million savings in the Medicare Trust Fund, during the 2024 performance year of the ACO Realizing Equity, Access and</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/agilon+health+Reports+ACO+REACH+Model+Results+for+2024+Performance+Year/26755441.html</guid>
   <pubDate>Fri, 10 Jul 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50348148</category>
   	  </item>
  <item>
   <title>agilon health Sets Date to Report Second Quarter 2026 Financial Results</title>
   <link>http://www.streetinsider.com/Press+Releases/agilon+health+Sets+Date+to+Report+Second+Quarter+2026+Financial+Results/26741763.html</link>
   <description>
&lt;p&gt;    WESTERVILLE, Ohio--(BUSINESS WIRE)--
agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that it will release financial results for the second quarter 2026 after market close on Wednesday, August 5, 2026 and host a conference call at 4:30 p.m. ET to discuss the results.

&lt;/p&gt;&lt;p&gt;
The conference call can be accessed by dialing (833) 439-1904 for U.S. participants and +1 (585) 542-9983 for international participants and referencing participant code 372460207. A simultaneous webcast can be accessed by visiting the “Events &amp;amp; Presentations” section of agilon’s Investor Relations website at</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/agilon+health+Sets+Date+to+Report+Second+Quarter+2026+Financial+Results/26741763.html</guid>
   <pubDate>Tue, 07 Jul 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50348148</category>
   	  </item>
  <item>
   <title>agilon health Sets Date to Report Second Quarter 2026 Financial Results</title>
   <link>http://www.streetinsider.com/Press+Releases/agilon+health+Sets+Date+to+Report+Second+Quarter+2026+Financial+Results/26741763.html</link>
   <description>
&lt;p&gt;    WESTERVILLE, Ohio--(BUSINESS WIRE)--
agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that it will release financial results for the second quarter 2026 after market close on Wednesday, August 5, 2026 and host a conference call at 4:30 p.m. ET to discuss the results.

&lt;/p&gt;&lt;p&gt;
The conference call can be accessed by dialing (833) 439-1904 for U.S. participants and +1 (585) 542-9983 for international participants and referencing participant code 372460207. A simultaneous webcast can be accessed by visiting the “Events &amp;amp; Presentations” section of agilon’s Investor Relations website at</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/agilon+health+Sets+Date+to+Report+Second+Quarter+2026+Financial+Results/26741763.html</guid>
   <pubDate>Tue, 07 Jul 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50348148</category>
   	  </item>
  <item>
   <title>agilon health Sets Date to Report Second Quarter 2026 Financial Results</title>
   <link>http://www.streetinsider.com/Business+Wire/agilon+health+Sets+Date+to+Report+Second+Quarter+2026+Financial+Results/26741763.html</link>
   <description>
&lt;p&gt;    WESTERVILLE, Ohio--(BUSINESS WIRE)--
agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that it will release financial results for the second quarter 2026 after market close on Wednesday, August 5, 2026 and host a conference call at 4:30 p.m. ET to discuss the results.

&lt;/p&gt;&lt;p&gt;
The conference call can be accessed by dialing (833) 439-1904 for U.S. participants and +1 (585) 542-9983 for international participants and referencing participant code 372460207. A simultaneous webcast can be accessed by visiting the “Events &amp;amp; Presentations” section of agilon’s Investor Relations website at</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/agilon+health+Sets+Date+to+Report+Second+Quarter+2026+Financial+Results/26741763.html</guid>
   <pubDate>Tue, 07 Jul 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AGL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.50348148</category>
   	  </item>
 </channel>
</rss>
